bendamustine hydrochloride
Date:2021-12-08 Categories:Related Application Product
| post date: |
dec 07,2021 |
| expiry date: |
jun 05,2022 |
| detailed description: |
cas no. :3543-75-7;97832-05-8
bendamustine hydrochloride 3543-75-7 |
| cas registry number: |
3543-75-7;97832-05-8
|
| synonyms: |
;bendamustin hydrochloride;cytostasan;1-methyl-5-bis(2-chloroethyl)amino-2-benzimidazolinebutryric acid hydrochloride;4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid hydrochloride;1-methyl-5-bis(2-chloroethyl)amino-2-benzimidazolinebutryricacihydrochlor;gamma(1-methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydro;bendamustine hcl;4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butyric acid hydrochloride;4-{5-[bis(2-chloroethyl)amino]-1-methyl-1h-benzimidazol-2-yl}butanoic acid hydrochloride (1:1);cytostasanhcl;treanda;bendamustin hcl; |
| molecular formula: |
c16h22cl3n3o2 |
| molecular weight: |
394.7238 |
| molecular structure: |
|